[68Ga]Ga-DOTA-TATE

gallium-68 DOTATATE · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [68Ga]Ga-DOTA-TATE, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan [Phase 3]

See pricing